X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1020) 1020
hypertension, pulmonary - drug therapy (613) 613
male (536) 536
female (516) 516
pulmonary hypertension (497) 497
epoprostenol - administration & dosage (411) 411
infusions, intravenous (395) 395
index medicus (388) 388
adult (387) 387
continuous intravenous epoprostenol (369) 369
middle aged (359) 359
prostacyclin (350) 350
cardiac & cardiovascular systems (318) 318
epoprostenol - therapeutic use (318) 318
hypertension, pulmonary - physiopathology (312) 312
respiratory system (310) 310
therapy (287) 287
antihypertensive agents - therapeutic use (279) 279
survival (271) 271
pulmonary arterial hypertension (253) 253
antihypertensive agents - administration & dosage (234) 234
treatment outcome (224) 224
epoprostenol (214) 214
animals (195) 195
aged (189) 189
hypertension (186) 186
double-blind (183) 183
epoprostenol - analogs & derivatives (183) 183
hypertension, pulmonary - diagnosis (178) 178
hypertension, pulmonary - etiology (172) 172
arterial-hypertension (167) 167
injections, intravenous (160) 160
inhaled iloprost (156) 156
intravenous epoprostenol (155) 155
medicine, general & internal (155) 155
drug therapy (147) 147
vasodilator agents - therapeutic use (146) 146
care and treatment (143) 143
pharmacology & pharmacy (143) 143
bosentan (138) 138
calcium-channel blockers (137) 137
placebo-controlled trial (134) 134
epoprostenol - pharmacology (130) 130
hemodynamics - drug effects (129) 129
inhaled nitric-oxide (127) 127
prostacyclin analog (125) 125
hypertension, pulmonary - therapy (124) 124
treprostinil (123) 123
iloprost (119) 119
drug therapy, combination (117) 117
endothelin receptor antagonists (108) 108
dose-response relationship, drug (107) 107
sildenafil (106) 106
blood pressure - drug effects (105) 105
hemodynamics (105) 105
intravenous epoprostenol prostacyclin (105) 105
disease (103) 103
prognosis (103) 103
epoprostenol - adverse effects (102) 102
controlled-trial (101) 101
infusion (100) 100
long-term treatment (99) 99
adolescent (98) 98
vasodilator agents - administration & dosage (98) 98
time factors (97) 97
administration, inhalation (96) 96
endothelin-receptor antagonist (96) 96
critical care medicine (91) 91
administration, oral (89) 89
familial primary pulmonary hypertension (89) 89
hypertension, pulmonary - mortality (85) 85
retrospective studies (85) 85
antihypertensive agents - adverse effects (84) 84
follow-up studies (84) 84
research (81) 81
sildenafil citrate (79) 79
diagnosis (77) 77
rats (77) 77
child (76) 76
nitric oxide (76) 76
pulmonary arteries (76) 76
scleroderma (76) 76
vascular resistance - drug effects (76) 76
lung transplantation (75) 75
abridged index medicus (74) 74
risk factors (74) 74
mortality (73) 73
endothelin (72) 72
hypertension, pulmonary - complications (72) 72
transplantation (70) 70
sulfonamides - therapeutic use (68) 68
health aspects (67) 67
severity of illness index (66) 66
combination therapy (64) 64
nitric-oxide (63) 63
iloprost - administration & dosage (62) 62
peripheral vascular disease (62) 62
scleroderma, systemic - complications (62) 62
brain natriuretic peptide (60) 60
surgery (60) 60
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Mt Sinai Hospital - Stacks (1) 1
Scarborough Hospital - General (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Toronto East General Hospital - Stacks (1) 1
Trillium Health Centre - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1214) 1214
German (36) 36
French (33) 33
Spanish (14) 14
Japanese (10) 10
Russian (10) 10
Polish (4) 4
Chinese (3) 3
Turkish (3) 3
Italian (2) 2
Czech (1) 1
Korean (1) 1
Norwegian (1) 1
Portuguese (1) 1
Slovak (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 03/2000, Volume 132, Issue 6, pp. 425 - 434
Journal Article
EUROPEAN RESPIRATORY JOURNAL, ISSN 0903-1936, 09/2004, Volume 24, Issue 3, pp. 353 - 359
The efficacy and safety of combining bosentan, an orally active dual endothelin receptor antagonist and epoprostenol, a continuously infused prostaglandin, in... 
SURVIVAL | CHRONIC HEART-FAILURE | epoprostenol | scleroderma | PROSTACYCLIN | TERM | CONTINUOUS INTRAVENOUS EPOPROSTENOL | SYSTEMIC-SCLEROSIS | EXCRETION | endothelin receptors | Bosentan | THERAPY | RESPIRATORY SYSTEM | ENDOTHELIN-RECEPTOR ANTAGONIST | pulmonary arterial hypertension | EXPRESSION
Journal Article
Chest, ISSN 0012-3692, 2006, Volume 130, Issue 5, pp. 1481 - 1488
Journal Article
American Heart Journal, ISSN 0002-8703, 2014, Volume 167, Issue 2, pp. 218 - 225.e1
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/1996, Volume 334, Issue 5, pp. 296 - 301
Journal Article
Journal of Heart and Lung Transplantation, ISSN 1053-2498, 2007, Volume 26, Issue 4, pp. 357 - 362
Journal Article
Journal Article